| Literature DB >> 30388863 |
Yu Qian1,2,3,4, Jing Zhang5, Xinwei Fu6, Ruokun Yi7,8,9, Peng Sun10,11,12,13, Mei Zou14,15, Xingyao Long16,17, Xin Zhao18,19,20.
Abstract
Liubao tea is a type of traditional Chinese tea, belonging to the dark teas. This study is a basic research of the contained polyphenols (active substances) and detected preventive effects of polyphenols of raw Liubao tea (PRLT) on mouse gastric injuries induced by HCl/ethanol. High-pressure liquid chromatography was used to analyze the components of PRLT. Furthermore, a mouse gastric injury model was established to observe the preventive effects. PRLT was shown to contain gallic acid, EGC (epigallocatechin), catechin, caffeine, EC (epicatechin), EGCG (epigallocatechin gallate), GCG (gallocatechin gallate), and ECG (epicatechin gallate). The results of the in vivo study indicate that PRLT can inhibit the observed increase of gastric juice volume and decrease of gastric juice pH caused by gastric injury. PRLT can decrease the serum levels of IL-6 (interleukin-6), IL-12 (interleukin-12), TNF-α (tumor necrosis factor-α), and IFN-γ (interferon-γ) in mice with gastric injuries. Moreover, it can also increase the serum levels of SS (somatostatin) and VIP (vasoactive intestinal peptide) and reduce the serum levels of both SP (substance P) and ET-1 (endothelin-1). PRLT was also shown to increase SOD (superoxide dismutase) and GSH (glutathione) levels and decrease MDA (malondialdehyde) level. The detection of mRNA and protein in gastric tissues indicates that PRLT could also up-regulate the expression of Cu/Zn-SOD (copper/zinc superoxide dismutase), Mn-SOD (manganese superoxide dismutase), CAT (catalase), nNOS (neuronal nitric oxide synthase), and eNOS (endothelial nitric oxide synthase) and down-regulate the expression of both iNOS (inducible nitric oxide synthase) and COX-2 (cyclooxygenase-2). Thus, PRLT possess a good preventive effect on gastric injury, which is directly related to the contained active substance. PRLT show good anti-oxidative and preventive effect in gastric injury and offer promising application value.Entities:
Keywords: Liubao tea; gastric injury; oxidative; polyphenol; protein
Mesh:
Substances:
Year: 2018 PMID: 30388863 PMCID: PMC6278666 DOI: 10.3390/molecules23112848
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Polyphenol constituents of polyphenols of raw Liubao tea (PRLT). (A) Standard chromatograms; (B) PRLT chromatograms. 1: gallic acid; 2: EGC (epigallocatechin); 3: catechin; 4: caffeine; 5: EC (epicatechin); 6: EGCG (epigallocatechin gallate); 7: GCG (gallocatechin gallate); and 8: ECG (epicatechin gallate).
Component content of polyphenols of raw Liubao tea (PRLT).
| CR (mg/L) | AR (mAU*min) | AX (mAU*min) | CX (mg/L) | |
|---|---|---|---|---|
| Gallic acid | 24.00 | 6.7469 | 2.4674 | 9.00 |
| EGC | 52.00 | 0.4357 | 0.3322 | 40.00 |
| Catechin | 21.00 | 1.6564 | 0.5913 | 7.00 |
| EC | 50.00 | 77.5151 | 3.0796 | 2.00 |
| EGCG | 50.00 | 35.1070 | 8.2827 | 12.00 |
| GCG | 45.00 | 3.1497 | 0.2794 | 4.00 |
| ECG | 62.00 | 13.5090 | 9.6461 | 44.00 |
| Caffeine | 90.00 | 67.7504 | 20.5444 | 27.00 |
EGC, epigallocatechin; EC, epicatechin; 6: EGCG, epigallocatechin gallate; GCG, gallocatechin gallate; and ECG, epicatechin gallate.
Gastric juice volume and pH value of gastric acid in experimental mice.
| Group | Gastric Juice Volume (mL) | pH Value of Gastric Acid |
|---|---|---|
| Normal | 0.034 ± 0.008 e | 4.700 ± 0.024 a |
| Control | 0.249 ± 0.017 a | 1.602 ± 0.043 e |
| Ranitidine | 0.089 ± 0.009 d | 4.012 ± 0.020 b |
| PRLT-L | 0.183 ± 0.019 b | 2.333 ± 0.023 d |
| PRLT-H | 0.121 ± 0.020 c | 3.429 ± 0.026 c |
Values presented are the mean ± standard deviation (N = 10/group). a–e Mean values with different letters in the same row are significantly different (p < 0.05) according to Duncan’s multiple-range test. PRLT-L: 100 mg/kg polyphenols of raw Liubao tea treatment; PRLT-H: 200 mg/kg polyphenols of raw Liubao tea treatment; and ranitidine: 50 mg/kg ranitidine treatment.
Figure 2Morphological observation of gastric injury in experimental mice. PRLT-L: 100 mg/kg polyphenols of raw Liubao tea treatment; PRLT-H: 200 mg/kg polyphenols of raw Liubao tea treatment; and ranitidine: 50 mg/kg ranitidine treatment.
Gastric injury area and inhibition rate of gastric injury in experimental mice.
| Group | Gastric Injury Area (cm2) | pH Value of Gastric Acid |
|---|---|---|
| Normal | 0.00 ± 0.00 e | 4.700 ± 0.024 a |
| Control | 1.25 ± 0.31 a | 1.602 ± 0.043 e |
| Ranitidine | 0.18 ± 0.05 d | 4.012 ± 0.020 b |
| PRLT-L | 0.88 ± 0.26 b | 2.333 ± 0.023 d |
| PRLT-H | 0.33 ± 0.09 c | 3.429 ± 0.026 c |
Values presented are the mean ± standard deviation (N = 10/group). a–e Mean values with different letters in the same row are significantly different (p < 0.05) according to Duncan’s multiple-range test. PRLT-L: 100 mg/kg polyphenols of raw Liubao tea treatment; PRLT-H: 200 mg/kg polyphenols of raw Liubao tea treatment; Ranitidine: 50 mg/kg ranitidine treatment.
Figure 3Histopathological observation of gastric tissue in experimental mice (40×). PRLT-L: 100 mg/kg polyphenols of raw Liubao tea treatment; PRLT-H: 200 mg/kg polyphenols of raw Liubao tea treatment; and ranitidine: 50 mg/kg ranitidine treatment.
Serum levels of SS, SP, VIP and ET-1 in mice.
| Group | SS (μg/L) | SP (μg/L) | VIP (μg/L) | ET-1 (μg/mL) |
|---|---|---|---|---|
| Normal | 144.60 ± 5.21 a | 69.66 ± 4.02 e | 112.65 ± 5.16 a | 56.87 ± 3.15 e |
| Control | 42.05 ± 1.89 e | 165.78 ± 5.12 a | 34.01 ± 2.77 e | 125.30 ± 5.56 a |
| Ranitidine | 121.56 ± 3.69 b | 106.19 ± 2.91 d | 101.29 ± 2.99 b | 66.36 ± 2.71 d |
| PRLT-L | 75.20 ± 3.17 d | 132.05 ± 4.39 b | 74.36 ± 3.13 d | 103.64 ± 4.03 b |
| PRLT-H | 105.82 ± 4.36 c | 116.18 ± 3.49 c | 91.71 ± 3.92 c | 75.29 ± 3.37 c |
Values presented are the mean ± standard deviation (N = 10/group). a–e Mean values with different letters in the same row are significantly different (p < 0.05) according to Duncan’s multiple-range test. PRLT-L: 100 mg/kg polyphenols of raw Liubao tea treatment; PRLT-H: 200 mg/kg polyphenols of raw Liubao tea treatment; Ranitidine: 50 mg/kg ranitidine treatment. SS: somatostatin; SP: substance P; VIP: vasoactive intestinal peptide; and ET-1: endothelin-1.
Serum cytokines levels of IL-6, IL-12, TNF-α and IFN-γ in mice.
| Group | IL-6 (pg/mL) | IL-12 (pg/mL) | TNF-α (pg/mL) | IFN-γ (pg/mL) |
|---|---|---|---|---|
| Normal | 41.08 ± 3.31 e | 189.75 ± 15.25 e | 35.21 ± 2.62 e | 24.65 ± 2.39 e |
| Control | 187.20 ± 6.33 a | 765.33 ± 31.08 a | 152.71 ± 8.32 a | 138.10 ± 6.82 a |
| Ranitidine | 78.26 ± 3.06 d | 267.12 ± 20.86 d | 51.87 ± 3.98 d | 39.71 ± 2.88 d |
| PRLT-L | 135.74 ± 5.21 b | 535.69 ± 21.88 b | 122.87 ± 6.91 b | 101.18 ± 5.31 b |
| PRLT-H | 84.65 ± 4.11 c | 318.78 ± 22.53c | 63.24 ± 4.87 c | 52.83 ± 4.37 c |
Values presented are the mean ± standard deviation (N = 10/group). a–e Mean values with different letters in the same row are significantly different (p < 0.05) according to Duncan’s multiple-range test. PRLT-L: 100 mg/kg polyphenols of raw Liubao tea treatment; PRLT-H: 200 mg/kg polyphenols of raw Liubao tea treatment; Ranitidine: 50 mg/kg ranitidine treatment. IL-6: interleukin-6; IL-12: interleukin-12; TNF-α: tumor necrosis factor-α; and IFN-γ: interferon-γ.
Levels of SOD, GSH and MDA in serum and gastric tissues of mice.
|
|
|
|
|
| Normal | 135.27 ± 6.39 a | 15.03 ± 1.12 a | 10.08 ± 0.25 e |
| Control | 51.07 ± 3.65 e | 3.57 ± 0.32 e | 69.71 ± 4.48 a |
| Ranitidine | 118.75 ± 3.56 b | 13.05 ± 0.44 b | 17.66 ± 1.82 d |
| PRLT-L | 79.82 ± 3.41 d | 7.71 ± 0.47 d | 47.52 ± 3.28 b |
| PRLT-H | 107.51 ± 4.46 c | 11.20 ± 0.39 c | 25.17 ± 3.59 c |
|
|
|
|
|
| Normal | 218.65 ± 21.08 a | 7.08 ± 0.26 a | 2.63 ± 0.31 e |
| Control | 89.37 ± 8.35 e | 0.97 ± 0.12 e | 10.11 ± 0.42 a |
| Ranitidine | 199.59 ± 9.36 b | 5.89 ± 0.14 b | 3.42 ± 0.28 d |
| PRLT-L | 132.10 ± 10.22 d | 2.39 ± 0.19 d | 7.32 ± 0.26 b |
| PRLT-H | 171.26 ± 8.97 c | 5.12 ± 0.12 c | 4.31 ± 0.33 c |
Values presented are the mean ± standard deviation (N = 10/group). a–e Mean values with different letters in the same row are significantly different (p < 0.05) according to Duncan’s multiple-range test. PRLT-L: 100 mg/kg polyphenols of raw Liubao tea treatment; PRLT-H: 200 mg/kg polyphenols of raw Liubao tea treatment; Ranitidine: 50 mg/kg ranitidine treatment. SOD: superoxide dismutase; GSH: glutathione; and MDA: malondialdehyde.
Figure 4Cu/Zn-SOD, Mn-SOD and CAT mRNA (A) and protein (B) expression in gastric tissues of mice. Values presented are the mean ± standard deviation (N = 3/group). a–e Mean values with different letters in the same bars are significantly different (p < 0.05) according to Duncan’s multiple-range test. PRLT-L: 100 mg/kg polyphenols of raw Liubao tea treatment; PRLT-H: 200 mg/kg polyphenols of raw Liubao tea treatment; Ranitidine: 50 mg/kg ranitidine treatment. Cu/Zn-SOD: copper/zinc superoxide dismutase; Mn-SOD: manganese superoxide dismutase; and CAT: catalase.
Figure 5nNOS, eNOS and iNOS mRNA (A) and protein (B) expression in gastric tissues of mice. Values presented are the mean ± standard deviation (N = 3/group). a–e Mean values with different letters in the same bars are significantly different (p < 0.05) according to Duncan’s multiple-range test. PRLT-L: 100 mg/kg polyphenols of raw Liubao tea treatment; PRLT-H: 200 mg/kg polyphenols of raw Liubao tea treatment; Ranitidine: 50 mg/kg ranitidine treatment. nNOS: neuronal nitric oxide synthase; eNOS: endothelial nitric oxide synthase; and iNOS: inducible nitric oxide synthase.
Figure 6COX-2 mRNA (A) and protein (B) expression in gastric tissues of mice. Values presented are the mean ± standard deviation (N = 3/group). a–e Mean values with different letters in the same bars are significantly different (p < 0.05) according to Duncan’s multiple-range test. PRLT-L: 100 mg/kg polyphenols of raw Liubao tea treatment; PRLT-H: 200 mg/kg polyphenols of raw Liubao tea treatment; and ranitidine: 50 mg/kg ranitidine treatment. COX-2: cyclooxygenase-2.
Gradient elution conditions for mobile phase.
| No. | Time (min) | Flow Rate (mL/min) | %A | %B |
|---|---|---|---|---|
| 1 | 0.0 | 0.6 | 90.0 | 10.0 |
| 2 | 6.5 | 0.6 | 81.5 | 18.5 |
| 3 | 27.5 | 0.6 | 64.5 | 35.5 |
| 4 | 32.5 | 0.6 | 0.0 | 100.0 |
| 5 | 42.5 | 0.6 | 0.0 | 100.0 |
Sequences of reverse transcription-polymerase chain reaction primers were used in this study.
| Gene Name | Sequence |
|---|---|
| Cu/Zn-SOD | Forward: 5′-GAA GAG AGG CAT GTT GGA GA-3′ |
| Reverse: 5′-CCA ATT ACA CCA CGA GCC AA-3′ | |
| Mn-SOD | Forward: 5′-TTC AAT AAG GAG CAG GGA C-3′ |
| Reverse: 5′-CAG TGT AAG GCT GAC GGT TT-3′ | |
| CAT | Forward: 5′-GGA GGC GGG AAC CCA ATA G-3′ |
| Reverse: 5′-GTG TGC CAT CTC GTC AGT GAA-3′ | |
| nNOS | Forward: 5′-ATG TCC TCA AAG CCA TCC AG-3′ |
| Reverse: 5′-ACT CAG ATC TAA GGC GGT TG-3′ | |
| eNOS | Forward: 5′-TGT CTG CGG CGA TGT CAC T-3′ |
| Reverse: 5′-CAT GCC GCC CTC TGT TG-3′ | |
| iNOS | Forward: 5′-CAG CTG GGC TGT ACA AAC CTT-3′ |
| Reverse: 5′-CAT TGG AAG TGA AGC GTT TGG-3′ | |
| COX-2 | Forward: 5′-TTA AAA TGA GAT TGT CCG AA-3′ |
| Reverse: 5′-AGA TCA CCT CTG CCT GAG TA-3′ | |
| GAPDH | Forward: 5′-TGC ACC ACC AAC TGC TTA G-3′ |
| Reverse: 5′-GAT GCA GGG ATG ATG TTC-3′ |
Cu/Zn-SOD, copper/zinc superoxide dismutase; Mn-SOD, manganese superoxide dismutase; CAT, catalase; nNOS, neuronal nitric oxide synthase; eNOS, endothelial nitric oxide synthase; iNOS, inducible nitric oxide synthase; COX-2, cyclooxygenase-2; and GAPDH, glyceraldehyde-3-phosphate dehydrogenase.